Skip to main content

Closed

CVM: CEL-SCI Corporation Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-143.2%

Financially safe

Stretched

Debt / equity1.24×

Interest coverage-43.9×

Current ratio0.60×

CEL-SCI Corporation

CVMNew York Stock Exchange Arca·USD·Closed

CEL-SCI Corporation

CVMNew York Stock Exchange Arca·USD·Closed

$1.36

+8.80%

$1.36

+$0.11 (8.80%)

52W Range

4thpctl

Volume

0.51×avg

Mkt Cap

9.35MUSD

P/E

-0.4TTM

Div Yield

–ann

52W Range

4thpctl

Volume

0.51×avg

Market Cap

9.35MUSD

P/E Ratio

-0.4TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings